Physician profile
Michael Hajdu
NPI 1912955683
$2,358.02
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $220 · 2021: $299 · 2022: $667 · 2023: $25.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $694.59 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $351.05 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $306.07 | 2019-2022 | |
| Pfizer INC. | $169.92 | 2019-2022 | |
| Amgen INC. | $164.55 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.84 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $83.12 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $77.46 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.05 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $69.77 | 2019-2022 | |
| Lundbeck LLC | $42.64 | 2019 | |
| Amarin Pharma, INC. | $42.16 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $37.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.43 | 2022 | |
| Angiodynamics, INC. | $27.89 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $25.20 | 2023 | Watchpatone |
| Lantheus Medical Imaging, INC. | $18.89 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.62 | 2021 | |
| Boston Scientific Corporation | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hajdu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.